BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Linzess (linaclotide) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Linzess (linaclotide)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03796884-10885@assetmemo.bio
DTSTAMP:20261121T005610Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:Linzess (linaclotide): Phase 2 readout est. (NCT03796884)
DESCRIPTION:Linzess (linaclotide)\, phase 2.\nStudy: Linaclotide in Treatin
 g Patients With Stages 0-3 Colorectal Cancer\nEstimated primary completion
 : November 2026. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/lina
 clotide#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT03796884
URL:https://assetmemo.bio/drug/linaclotide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07431957-10885@assetmemo.bio
DTSTAMP:20261121T005610Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Linzess (linaclotide): Phase 4 readout est. (NCT07431957)
DESCRIPTION:Linzess (linaclotide)\, phase 4\, Irritable Bowel Syndrome with
  Constipation.\nStudy: "Efficacy and Safety of Linaclotide in Chronic Cons
 tipation"\nEstimated primary completion: 31 December 2026. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/linaclotide#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT07431957
URL:https://assetmemo.bio/drug/linaclotide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07780344-10885@assetmemo.bio
DTSTAMP:20261121T005610Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:Linzess (linaclotide): Phase na readout est. (NCT07780344)
DESCRIPTION:Linzess (linaclotide)\, phase na.\nStudy: MRI Parameters as Bio
 markers in Cystic Fibrosis (FEMPTO)\nEstimated primary completion: May 202
 7. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/linaclotide#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT07780344
URL:https://assetmemo.bio/drug/linaclotide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
